Which second-line treatment regimen should be used following relapse of platinum-sensitive ovarian cancer?
- PMID: 17406383
- DOI: 10.1038/ncponc0795
Which second-line treatment regimen should be used following relapse of platinum-sensitive ovarian cancer?
Comment on
-
Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON4/AGO-OVAR-2.2 trial.Lancet. 2003 Jun 21;361(9375):2099-106. doi: 10.1016/s0140-6736(03)13718-x. Lancet. 2003. PMID: 12826431 Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources